Abbott raises annual earnings outlook as COVID-19 test sales rebound
Go back to Abbott raises annual earnings outlook as COVID-19 test sales rebound| Abbott Laboratories (NYSE: ABT) | Delayed: 102.36 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $102.36 | 52 Week High | $46.38 | |||
| Open | $102.36 | 52 Week Low | $36.00 | |||
| Day High | $102.36 | P/E | 68.24 | |||
| Day Low | $102.36 | EPS | $1.50 | |||
| Volume | 1,552 | |||||
